Researchers have identified a new subtype of prostate cancer that occurs in about 7% of patients with advanced diseases. The subtype is characterised by loss of the gene CDK12. It was found to be a more common in metastatic prostate cancer compared to early stage tumours that had not spread, ... Read More »
Too embarrassed to get your prostate checked? Gareth Brown, Consultant Urological Surgeon at Nuffield Health, explains why it’s well worth a few awkward moments. When I meet a man to check his prostate, the first thing I do is shake his hand. That’s the point when many of them realise I have ... Read More »
THURSDAY, July 28, 2016 — Men with low-risk prostate cancer report a good quality of life after choosing active surveillance as a treatment for their disease, a new study finds. Active surveillance for prostate cancer means a man chooses not to have surgery, radiation or chemotherapy, but instead follows a ... Read More »
Researchers in England have identified a large group of genes that may be significant for better testing and treatment of prostate cancer. Glycan sugar groups on the surface of prostate cancer cells were found to react to changes in testosterone levels that help the disease grow and spread, and may ... Read More »
Screening and treatment guidelines may need to be intensified because rates of metastatic prostate cancer have increased by nearly three-quarters during the last decade, researchers suggest after a recent study. Researchers at Northwestern University report more men with metastatic prostate cancer are being diagnosed with worse and more aggressive tumors, ... Read More »
COLUMBIA, S.C., April 14 — A drug designed to lower cholesterol stops the progression of prostate cancer, according to researchers at the University of Missouri. The researchers say using the drug with or without chemotherapy treatments for prostate cancer could prove to be more effective while reducing the level of ... Read More »
WEDNESDAY, April 6, 2016 — Higher doses of radiation may not benefit low-risk prostate cancer patients, a new review suggests. “In the field of radiation oncology, we often assume that the highest dose that the body can tolerate will be most effective at killing cancer,” said senior study author Dr. ... Read More »
